Development of a rapid detection method for the macrolide resistance gene in Mycobacterium avium using the amplification refractory mutation system–loop-mediated isothermal amplification method

Author:

Inagaki Takayuki12ORCID,Asahi Shoki3,Ogawa Kenji4,Nakagawa Taku4,Ohkura Teruko5,Osada Yukari5,Nikai Toshiaki6,Yamada Kiyofumi7,Yagi Tetsuya8,Uchiya Kei-ichi6ORCID

Affiliation:

1. Division of Pharmaceutical Sciences I, Faculty of Pharmacy, Meijo University, Nagoya, Aichi, Japan

2. Department of Hospital Pharmacy, Nagoya University Hospital, Nagoya, Aichi, Japan

3. Department of Hospital Pharmacy, Japan Organization of Occupational Health and Safety, Chubu Rosai Hospital, Nagoya, Aichi, Japan

4. Department of Respiratory Medicine, National Hospital Organization, Higashinagoya National Hospital, Nagoya, Aichi, Japan

5. Department of Medical Technique, Nagoya University Hospital, Nagoya, Aichi, Japan

6. Department of Microbiology, Faculty of Pharmacy, Meijo University, Nagoya, Aichi, Japan

7. Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

8. Department of Infectious Diseases, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

Abstract

ABSTRACT Macrolide antibiotics such as clarithromycin (CLR) and azithromycin are the key drugs used in multidrug therapy for Mycobacterium avium complex (MAC) diseases. For these antibacterial drugs, drug susceptibility has been correlated with clinical response in MAC diseases. We have previously demonstrated the correlation between drug susceptibility and mutations in the 23S rRNA gene, which confers resistance to macrolides. Herein, we developed a rapid detection method using the amplification refractory mutation system (ARMS)–loop-mediated isothermal amplification (LAMP) technique to identify mutations in the 23S rRNA gene of M. avium . We examined the applicability of the ARMS–LAMP method to genomic DNA extracted from six genotypes of M. avium clinical isolates. The M. avium isolates were classified into 21 CLR-resistant and 9 CLR-susceptible strains based on the results of drug susceptibility tests; the 23S rRNA genes of these strains were sequenced and analyzed using the ARMS–LAMP method. Sequence analysis revealed that the 9 CLR-sensitive strains were wild-type strains, whereas the 21 CLR-resistant strains comprised 20 mutant-type strains and one wild-type strain. Using ARMS–LAMP, no amplification from genomic DNAs of the 10 wild-type strains was observed using the mutant-type mismatch primer sets (MTPSs); however, amplification from the 20 mutant-type strain DNAs was observed using the MTPSs. The rapid detection method developed by us integrates ARMS–LAMP with a real-time turbidimeter, which can help determine drug resistance in a few hours. In conclusion, ARMS–LAMP might be a new clinically beneficial technology for rapid detection of mutations. IMPORTANCE Multidrug therapy for pulmonary Mycobacterium avium complex disease is centered on the macrolide antibiotics clarithromycin and azithromycin, and resistance to macrolides is an important prognosticator for clinical aggravation. Therefore, it is important to develop a quick and easy method for detecting resistance to macrolides. Drug resistance is known to be correlated with mutations in macrolide resistance genes. We developed a rapid detection method using amplification refractory mutation system (ARMS)–loop-mediated isothermal amplification (LAMP) to identify a mutation in the 23S rRNA gene, which is a macrolide resistance gene. Furthermore, we examined the applicability of this method using M. avium clinical isolates. The rapid method developed by us for detection of the macrolide resistance gene by integrating ARMS–LAMP and a real-time turbidimeter can help in detection of drug resistance within a few hours. Since this method does not require expensive equipment or special techniques and shows high analytical speed, it would be very useful in clinical practice.

Funder

MEXT | Japan Society for the Promotion of Science

Publisher

American Society for Microbiology

Reference27 articles.

1. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases

2. Opinions on chemotherapy of non-tuberculous acid-fast bacterial infection of the lung;Committee on Management of Non-Tuberculous Acid-Fast Bacterial Infection, Japanese Society of Tuberculosis; Infection and Tuberculosis Section of Japanese Society of Respiratory Diseases;Kekkaku,2012

3. Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

4. Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan1

5. Activity of Clarithromycin againstMycobacterium aviumInfection in Patients with the Acquired Immune Deficiency Syndrome: A Controlled Clinical Trial

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3